Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
120 participants
OBSERVATIONAL
2009-10-31
2010-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, a specific serum-biomarker in lung diseases has not been established. Aim of the current study is to to measure lung specific proteins in the serum in patients with various lung diseases and to correlate those with disease severity, lung function and other laboratory results
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biomarkers for Diagnosis and Treatment of COPD
NCT02633280
Biomarkers of Early Chronic Obstructive Pulmonary Disease (COPD) in Smokers - Longitudinal Study
NCT02076061
Novel Biomarkers in Chronic Airway Diseases
NCT00849836
Breath Analysis Based Disease Biomarkers
NCT04341012
Immune Checkpoints in COPD
NCT04654104
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
lung disease
patients with various chronic or acute lung diseases
biomarker
measuring serum-biomarkers
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
biomarker
measuring serum-biomarkers
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* acute or chronic lung disease
Exclusion Criteria
* lactation or gestation
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heidelberg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thoraxklinik Heidelberg
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michael Kreuter, MD
Role: PRINCIPAL_INVESTIGATOR
Thoraxklinik Heidelberg, Germany
Felix JF Herth, MD
Role: STUDY_DIRECTOR
Thoraxklinik Heidelberg Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Thoraxklinik Heidelberg, Dept. of Pneumology and Respiratory Critical care
Heidelberg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Tzouvelekis A, Pneumatikos I, Bouros D. Serum biomarkers in acute respiratory distress syndrome an ailing prognosticator. Respir Res. 2005 Jun 22;6(1):62. doi: 10.1186/1465-9921-6-62.
Tzouvelekis A, Kouliatsis G, Anevlavis S, Bouros D. Serum biomarkers in interstitial lung diseases. Respir Res. 2005 Jul 21;6(1):78. doi: 10.1186/1465-9921-6-78.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MK02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.